Shares of Compass Pathways fell after the company recorded a wider-than-expected fourth-quarter loss. Shares were down 3.3% to $5.17 in Tuesday morning trading. The stock is up 66% over the past year.

COMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect in treatment resistant depression (TRD), with a generally ...

COMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect in treatment resistant depression (TRD), with a generally ...

Compass Pathways (NASDAQ:CMPS) executives outlined plans for a potential U.S. regulatory filing and commercial launch preparation for its investigational psilocybin therapy, COMP360, during a recent ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Digbi Health, the leader in precision biology for metabolic and digestive health, today announced a major expansion of its GLP-1 Compass™ platform with the launch of Digbi RxFund™. This industry-first ...

Catering News is sponsored by The Kitchen Porters Club Compass Group UK and Ireland is celebrating three years of impact through its partnership with The Compass Group Foundation, the Group’s ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the ...

Detailed price information for Gh Research Plc (GHRS-Q) from The Globe and Mail including charting and trades.

Detailed price information for Compass Pathways Plc ADR (CMPS-Q) from The Globe and Mail including charting and trades.

A new Johns Hopkins study found that a single dose of psilocybin, combined with therapy, helped smokers stay cigarette‑free at six months far more effectively than nicotine patches ・Participants using ...

The net proceeds from these warrant exercises, along with the net proceeds of approximately $141 million from the recent public offering that closed on February 20, 2026, and its existing cash and ...